Hilary DuBrock, MD
@hilarydubrockMD
#pulmonaryhypertension physician and PH fellowship director @MayoClinic by way of @bidmc_im and @MGH_PCCM /mother of 3/tweets are my own
ID:3222703372
30-04-2015 00:19:55
99 Tweets
262 Followers
219 Following
Happy to see our paper published JHLT ! Liver stiffness in PH is underestimated!@RyanTedfordMD Rebecca Vanderpool, PhD Roberto J. Bernardo, MD, MS, ATSF 🇵🇪🇺🇸 Matt Siuba Kurt Prins Jean-Luc Vachiery 🫀 Mark Toshner monta
📣📣 Check out the next episode of our #PracticalPH series! I’m joined by Hilary DuBrock, MD to talk about all things #pulmonaryhypertension fellowship! ATS PC Assembly American Thoracic Society (ATS) Assemblies of American Thoracic Society ATS Early Career ATS Section on #MedEd MayoPCCM Mayo Clinic CV
breatheeasy.transistor.fm/episodes/pract…
Our latest work: Quantitative CT measures of pulmonary vascular volume distribution in pulmonary hypertension associated with COPD: Association with clinical characteristics and outcomes - Cajigas - 2023 - Pulmonary Circulation - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/pu…
Nice issue lead by Hilary DuBrock, MD
Check out our paper Jean M. Elwing IU Pulmonary and Critical Care Fellowship
Hot off the press! Pts w/ #PH are at risk of #adverseoutcomes during #intubation ..but just how much? Kavitha Gopalratnam Hilary DuBrock, MD Kathryn del Valle, MD Ognjen Gajic & team assess #outcomes in pts w/PH intubated in the #ICU . MayoPCCM Mayo Clinic CV ATS Early Career journals.sagepub.com/doi/10.1177/08…
It's National Pulmonary Rehabilitation (PR) Awareness Week!📣 PR improves breathlessness, physical function, & quality of life better than any other therapy. PR Assembly is sharing information & resources all week long. Follow along for more! #PulmonaryRehabilitation
Cardiac index & hepatopulmonary syndrome in liver #transplant ation candidates: The Pulmonary Vascular Complications of Liver Disease Study
journals.lww.com/lt/Abstract/99…
@Hilarydubrockmd @stevenkawut @alnaamani_N Karen Krok @grace_lin_md @jaekoh2 Mike Fallon, MD
#livertwitter #transplant
Editorial -
Portopulmonary hypertension: May we agree to disagree?
by Dr. Michael Krowka and Dr. Patrick Kamath of Mayo Clinic Gastroenterology & Hepatology
journals.lww.com/lt/Citation/99…
#livertwitter
Excited to share our work evaluating trends in #MELDexceptions for #POPH since they began in 2006, and so grateful for the amazing #mentorship and support from Hilary DuBrock, MD Julie Heimbach Timucin Taner & Dr. Michael Krowka! MayoPCCM Mayo Clinic Transplant Mayo Clinic Transplantation Surgery
🔥New manuscript alert! Katherine Cox-Flaherty MD ScM Nadine Al-Naamani Hilary DuBrock, MD et al describe the relationship between 6MWD and outcomes in a liver transplant cohort. A 50m decrease correlated to increased mortality, hospitalizations, and patient reported QoL!
tinyurl.com/4vzft3s2
Pulmonologist and PH clinician from Mayo Clinic, Hilary DuBrock, MD discusses portopulmonary hypertension, a type of pulmonary arterial hypertension that develops in the setting of portal hypertension and liver disease. phaware® podcast ep 398 #phawaremd phawarepodcast.libsyn.com/episode-398-hi…
Portopulmonary Hypertension in Nontransplanted Patients: Results of the Largest US Single-Institution Registry Very important info!- Mayo Clinic Proceedings. MayoPCCM Hilary DuBrock, MD Charles D Burger, MD Andrew Keaveny, M.D. mayoclinicproceedings.org/article/S0025-…
Optimal end-point selection for selecting PH-specific HRQoL requires consideration of the purpose and situation in which the assessment will be conducted. Read the full #CHESTReview in the November CHEST® Journal issue: hubs.la/Q01rGVcy0
#MedEd #MedTwitter
Check out our recent article describing the value of assessing PROs in PAH… HrQOL is important and the cognitive/emotional impact is independently prognostic onlinelibrary.wiley.com/doi/10.1002/pu… Vidhu Anand, MD, FACC, FASE MayoPCCM Garvan Kane Hector Cajigas #robertfrantz #yogeshreddy Pulmonary Circulation
Early initiation and uptitration of inhaled treprostinil offers patients with pulmonary hypertension due to fibrotic interstitial lung disease the greatest benefit with respect to improvement CHEST® Journal Hilary DuBrock, MD Sudarshan Rajagopal Sandeep Sahay, MD, MSc
fal.cn/3sBJY